Thin basement membrane disease cost-effectiveness of therapy: Difference between revisions
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
The cost of the supportive therapy for symptoms are not very expensive except long term dialysis and renal | The cost of the supportive [[therapy]] for symptoms are not very expensive except long term [[dialysis]] and [[renal transplantation]]. | ||
==Cost-effectiveness== | ==Cost-effectiveness== | ||
The cost-effectiveness of the supportive therapy for symptoms are not very costly. But patient with Renal impairment or renal failure should be counselled on cost of a long tern dialysis or renal | The [[cost-effectiveness]] of the supportive [[therapy]] for symptoms are not very costly. But patient with [[Renal impairment]] or [[renal failure]] should be counselled on cost of a long tern [[dialysis]] or [[renal transplantation]]. Moreover, the [[frequency]] of [[screening]] procedures may cause burden to a patient or the family's physical and [[mental health]]. The importance of early [[diagnosis]] and [[treatment]] should be explained in meaningful way. | ||
==References== | ==References== |
Revision as of 08:10, 20 October 2020
Thin basement membrane disease Microchapters |
Differentiating Thin basement membrane disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Thin basement membrane disease cost-effectiveness of therapy On the Web |
American Roentgen Ray Society Images of Thin basement membrane disease cost-effectiveness of therapy |
FDA on Thin basement membrane disease cost-effectiveness of therapy |
CDC on Thin basement membrane disease cost-effectiveness of therapy |
Thin basement membrane disease cost-effectiveness of therapy in the news |
Blogs on Thin basement membrane disease cost-effectiveness of therapy |
Directions to Hospitals Treating Thin basement membrane disease |
Risk calculators and risk factors for Thin basement membrane disease cost-effectiveness of therapy |
Overview
The cost of the supportive therapy for symptoms are not very expensive except long term dialysis and renal transplantation.
Cost-effectiveness
The cost-effectiveness of the supportive therapy for symptoms are not very costly. But patient with Renal impairment or renal failure should be counselled on cost of a long tern dialysis or renal transplantation. Moreover, the frequency of screening procedures may cause burden to a patient or the family's physical and mental health. The importance of early diagnosis and treatment should be explained in meaningful way.